Brainstorm Cell Therapeutics Inc. (BCLI)

SG&A Expenses

$696.00K

TTM · Period ending: · USD

BCLI logo

BCLI SG&A Expenses

Latest reported$696.00K
BCLI SG&A Expenses ($23.80K → $696.00K)
High-resolution chart · PNG

BCLI sg&a expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Brainstorm Cell Therapeutics Inc. SG&A Expenses — Annual fiscal periods (USD)
Period endingSG&A Expenses (USD)
5,778,000
7,042,000
10,693,000
10,866,000
9,304,000
9,355,000
5,797,000
5,770,000
4,022,000
2,833,000
3,587,000
2,649,000
2,101,000
1,748,000
2,205,000
1,544,000
1,569,000
1,629,000
2,990,000
2,139,637
2,476,553
47,233
36,424
23,801
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.